Innate Pharma SA 20-F for FY2022
Innate Pharma SA (IPHA)
20-F
2023-04-06
For: 2022-12-31
View Original
Added on
April 06, 2026
About this 20-F
Innate Pharma SA filed this 20-F on April 6, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 57.67M EUR
- up 133.5% from 24.7M EUR a year earlier
- Net loss
- 58.1M EUR
- compared with a net loss of 52.81M EUR a year earlier
- Diluted EPS
- -0.73 EUR
- compared with -0.66 EUR a year earlier